Phibro Animal Health | PAHC - Ativo Circulante





Ativo Circulante Alterar Data
Align Technology USD 2.62B 82.47M 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Henry Schein USD 4.46B 69M 2025-12
Idexx Laboratories USD 1.41B 63.23M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Pacira USD 547.97M 14.78M 2025-12
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Zoetis USD 6.77B 185M 2025-12